Basit öğe kaydını göster

dc.contributor.authorDemirkiran, M
dc.contributor.authorAgaoglu, J
dc.contributor.authorTuran, F
dc.contributor.authorOzmenoglu, M
dc.contributor.authorTogrul, E
dc.contributor.authorKantarci, O
dc.contributor.authorSiva, A
dc.contributor.authorEraksoy, M
dc.contributor.authorKarabudak, R
dc.contributor.authorSutlas, N
dc.date.accessioned2021-03-06T12:52:15Z
dc.date.available2021-03-06T12:52:15Z
dc.date.issued1998
dc.identifier.citationKantarci O., Siva A., Eraksoy M., Karabudak R., Sutlas N., Agaoglu J., Turan F., Ozmenoglu M., Togrul E., Demirkiran M., "Survival and predictors of disability in Turkish MS patients", NEUROLOGY, cilt.51, ss.765-772, 1998
dc.identifier.issn0028-3878
dc.identifier.othervv_1032021
dc.identifier.otherav_f5f5a3b4-4951-460a-980d-77d9d5f24264
dc.identifier.urihttp://hdl.handle.net/20.500.12627/161166
dc.identifier.urihttps://doi.org/10.1212/wnl.51.3.765
dc.description.abstractObjective: To examine the natural history, survival, and prognostic factors in a sample of Turkish MS patients. Method: This multicenter study included 1,259 definite MS patients diagnosed according to the criteria of Poser et al. Actuarial analysis of selected disability levels of 3, 6, 8, and 10 achieved with the Expanded Disability Status Scale (EDSS); a multivariate Cox regression analysis for prognostic factors related to time to reach EDSS greater than or equal to 6; and Pearson's correlation coefficient for individual factors were performed. Results: The survival (+/- SE) at 15 years from onset was 94.6 +/- 2.9%, and at 25 years was 89.0 +/- 5.8%. The disability reached by 15 years was EDSS greater than or equal to 3 in 66.4%, EDSS greater than or equal to 6 in 41.2%, EDSS greater than or equal to 8 in 10.5%, and EDSS = 10 in 5.4%. The most significant unfavorable prognostic factors were progressive course (relative risk [RR], 3.73; CI, 2.71 to 5.13) and sphincter symptoms at onset (RR, 1.86; CI, 1.23 to 2.82), followed by male sex, motor symptoms at onset, and a high attack frequency within the first 5 years. Primary progressive disease was correlated positively with male sex (r = 0.0895, p = 0.001), older age (I = 0.1807, p = 0.000), and motor (r = 0.1433, p = 0.000) or sphincter symptoms (r = 0.1001, p = 0.000) at onset, unlike relapsing-remitting and secondary progressive disease. Conclusions: Although a slightly better prognosis is observed in the Turkish MS population, early prognostic factors are similar to most of the previous Western series. Primary progressive disease, mostly seen in older men with motor and sphincter involvement at onset, has a worse prognosis and may represent a distinct behavioral variant of MS.
dc.language.isoeng
dc.subjectNöroloji
dc.subjectKLİNİK NEUROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.titleSurvival and predictors of disability in Turkish MS patients
dc.typeMakale
dc.relation.journalNEUROLOGY
dc.contributor.department, ,
dc.identifier.volume51
dc.identifier.issue3
dc.identifier.startpage765
dc.identifier.endpage772
dc.contributor.firstauthorID121460


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster